Skip to main content.

vaccine development

Picture of The Reporting on Health Collaborative

In 2002, when her two-month-old daughter Jayden developed a fever, Jillian Lugo just thought her baby was getting her first cold. Little did she know that Jayden had contracted valley fever. Here's what happened next.

Picture of The Reporting on Health Collaborative

Having another chronic disease like diabetes, arthritis or cancer may increase the risk of dying from valley fever, a new study suggests.

Picture of The Reporting on Health Collaborative

Scientists researching a vaccine for valley fever take different scientific approaches to their work. Some have been stymied by a lack of funding for their work.

Picture of The Reporting on Health Collaborative

There are arguments for developing a valley fever vaccine, but it can’t happen without a breakthrough in research — or more public funding.

Picture of The Reporting on Health Collaborative

After years of promising developments, the effort to produce a valley fever vaccine was all but terminated because of a lack of funding and industry interest. Yet some still hope to see a vaccine on the market.

Announcements

The nation’s overdose epidemic has entered a devastating new phase. Drugs laced with fentanyl and even more poisonous synthetics have flooded the streets, as the crisis spreads well beyond the rural, largely white communities that initially drew attention. The death rate is escalating twice as fast among Black people than among white people. This webinar will give journalists deep insights, fresh story ideas and practical tips for covering an epidemic that killed more than 107,000 people in the U.S. last year. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth